Skip to main content
Home > Week in Review > Other News

Chronological Index of BioCentury, Week in Review: Other News

BioCentury, Week in Review Current Issue
  • Illumina, Columbia University genomics news

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Columbia University, New York, N.Y. Business: Genomics The university trustees filed suit in the U.S. District Court for the District of Delaware alleging Illumina is …

    Published on 4/2/2012
  • Isotechnika, ILJIN autoimmune, transplant news

    Isotechnika Pharma Inc. (TSX:ISA), Edmonton, Alberta ILJIN Group, Seoul, South Korea Business: Autoimmune, Transplant Isotechnika said ILJIN's ILJIN Life Science Co. Ltd. subsidiary submitted a request for arbitration …

    Published on 4/2/2012
  • MagForce cancer news

    MagForce AG (Xetra:MF6), Berlin, Germany Business: Cancer MagForce reduced headcount by 11 (27%) to 30 to concentrate on clinical activities to support the launch of NanoTherm therapy. MagForce said 2011 revenues were …

    Published on 4/2/2012
  • Myriad Genetics, American Civil Liberties Union, Public Patent Foundation (PUBPAT), University of Utah Research Foundation diagnostic news

    Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah American Civil Liberties Union, New York, N.Y. Public Patent Foundation (PUBPAT), New York, N.Y. University of Utah Research Foundation, Salt Lake City, Utah …

    Published on 4/2/2012
  • Novartis, Broad Institute cancer, genomics news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Broad Institute, Cambridge, Mass. Business: Cancer, Genomics Novartis and the Broad Institute of MIT and Harvard launched the Cancer Cell Line Encyclopedia (CCLE) …

    Published on 4/2/2012
  • Orion, Mylan, Novartis neurology news

    Orion Corp. (HSE:ORNAV; HSE:ORNBV), Espoo, Finland Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Neurology Orion said it received notice that Mylan filed an ANDA…

    Published on 4/2/2012
  • Qiagen, Shanghai Jiao Tong University other news

    Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Shanghai Jiao Tong University, Shanghai, China Business: Other Qiagen partnered with the university's Bio-X Center to open a joint translational medicine lab …

    Published on 4/2/2012
  • Rhenovia neurology, musculoskeletal news

    Rhenovia Pharma S.A.S., Mulhouse, France Business: Neurology, Musculoskeletal Rhenovia launched drug discovery programs in Orphan and neglected diseases, with an initial focus on Huntington's disease and Duchenne …

    Published on 4/2/2012
  • Abbott pharmaceuticals news

    Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Business: Pharmaceuticals Abbott said "AbbVie" will be the name of the new, independent pharmaceutical business resulting from the split of Abbott into two public …

    Published on 3/26/2012
  • Amarin cardiovascular news

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Cardiovascular The U.S. Patent and Trademark Office (PTO) issued a Notice of Allowance for Amarin's Patent Application No. 12/052,598 covering lead product …

    Published on 3/26/2012
  • Apotex, U.S. Food and Drug Administration generics news

    Apotex Inc., Toronto, Ontario U.S. Food and Drug Administration, Silver Spring, Md. Business: Generics Apotex filed a request for arbitration against FDA in the International Centre for Settlement of Investment Disputes…

    Published on 3/26/2012
  • GlaxoSmithKline pharmaceuticals news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals GlaxoSmithKline said it will invest about 530 million ($838.8 million) for manufacturing in the U.K., including 350 million ($553.9 million…

    Published on 3/26/2012
  • Neurologix neurology news

    Neurologix Inc. (Pink:NRGXQ), Fort Lee, N.J. Business: Neurology Neurologix filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. According to the filed documents, the company had $1.…

    Published on 3/26/2012
  • Novartis, Massachusetts Institute of Technology chemistry, supply/service news

    NovartisAG (NYSE:NVS; SIX:NOVN), Basel, Switzerland MassachusettsInstitute of Technology, Cambridge, Mass. Business: Chemistry, Supply/Service In 2011, Novartis began building a pilot, multi-purpose, non-GMP, continuous…

    Published on 3/26/2012
  • Novartis, Walgreens Co. other news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Walgreens Co. (NYSE:WAG), Deerfield, Ill. Business: Other Novartis said it is working with pharmacy and drugstore chain Walgreens to establish the pharma's Clinical …

    Published on 3/26/2012
  • Prometheus, Mayo Collaborative Services Inc. diagnostic news

    Prometheus Laboratories Inc., San Diego, Calif. Mayo Collaborative Services Inc., Rochester, Minn. Business: Diagnostic The U.S. Supreme Court ruled 9-0 that two patents from Prometheus on the use of biomarkers to help …

    Published on 3/26/2012
  • Proteome Sciences neurology news

    Proteome Sciences plc (LSE:PRM), Cobham, U.K. Business: Neurology Proteome said that Euro-HYP, a consortium of academic and industry partners, received a grant of almost 11 million ($14.5 million) under the European …

    Published on 3/26/2012
  • Roche, Autism Speaks, King's College London neurology news

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Autism Speaks, New York, N.Y. King's College London, London, U.K. Business: Neurology Roche, King's College and advocacy group Autism Speaks launched a five-year research…

    Published on 3/26/2012
  • Unigene, Apotex musculoskeletal news

    Unigene Laboratories Inc. (OTCBB:UGNE), Boonton, N.J. Apotex Inc., Toronto, Ontario Business: Musculoskeletal The U.S. Supreme Court denied a petition from generics company Apotex to review a decision from the U.S. …

    Published on 3/26/2012
  • United Therapeutics, Novartis cardiovascular news

    United Therapeutics Corp. (NASDAQ:UTHR), Silver Spring, Md. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cardiovascular United Therapeutics filed suit in the U.S. District Court for the District of New…

    Published on 3/26/2012
  • Onyx, Bayer, Natco Pharma Ltd. cancer, generics news

    Onyx Pharmaceuticals Inc. (NASDAQ:ONXX), South San Francisco, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Natco Pharma Ltd. (BSE:NATCOPHAR), Hyderabad, India Business: Cancer, Generics The Indian Patent Office …

    Published on 3/19/2012
  • Paion cardiovascular, neurology news

    Paion AG (Xetra:PA8), Aachen, Germany Business: Cardiovascular, Neurology Paion issued an update for its ongoing restructuring will now reduce headcount to 11 employees. Late last year, Paion said it would reduce …

    Published on 3/19/2012
  • PolyPid drug delivery, infectious news

    PolyPid Ltd., Ness Ziona, Israel Business: Drug delivery, Infectious PolyPid joined the Biofilm Alliance (BALI) consortium and received a 1 million ($1.3 million) grant under the European Commission's Framework …

    Published on 3/19/2012
  • Teva endocrine/metabolic news

    Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel Business: Endocrine/Metabolic Teva filed a motion to intervene in the Center for Reproductive Rights' suit against FDA that is seeking unrestricted …

    Published on 3/19/2012
  • Watson Laboratories Inc., Alkem Laboratories, Amerigen Pharmaceuticals Ltd., Forest Laboratories, Glenmark, Hetero Drugs Ltd., Indchemie Health Specialties Pvt. Ltd., J&J, Torrent cardiovascular ...

    Watson Laboratories Inc. (NYSE:WPI), Parsippany, N.J. Alkem Laboratories Ltd., Mumbai, India Amerigen Pharmaceuticals Ltd., East Brunswick, N.J. Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Glenmark …

    Published on 3/19/2012

< Previous   1  2  3  4  5  6  7  8  9  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993

Log In


Forgot password  |  Forgot Login


If you are a subscriber, but have forgotten or have never received a password, please go here and ask us to send you a new one.

Catalent

Week in Review

The biotech industry's most complete compendium of corporate, clinical and financial transactions provides an efficient surveillance system for:

  • Deals
  • Regulatory Events
  • Clinical Results
  • Financings
  • Management News

Need custom ComputerVision Software?